Aims: OFICA is a nationwide, observational study of characteristics, management and outcome of acute heart failure (AHF) during hospitalization as well as after discharge.
Results:
The survey included 1817 patients (77±13y, 45% females) in 170 centers from cardiology wards (58%) as well intensive care units (18%) and internal medicine (24%). Before definitive admission at hospital, most patients were firstly examined by family doctors (41%) or cardiologist (18%). Mobile medical units were required in 33% of cases and patients were admitted in cardiac intensive care unit in 41% of cases. In-hospital mortality was 8.8%. Most survivors were discharged at home (66%) or in rehabilitation centers (5%) or in nursing homes (19%). Patients were followed by family doctors in 63% of cases, private cardiologists in 33% and hospital doctors in 32%; only 5% were included in HF networks or ambulatory HF units. At 3 months, the rate of allcause death was 17.8% and the rate of hospitalization was 30.9%.
Conclusion:
The OFICA survey is a valuable tool for analyzing AHF in the real life because of a large inclusion of unselected patients in different types of hospitals as well as departments. Family doctors play an important role as a first step management before admission as well after discharge while use of rehabilitation centers or HF units is marginal. High rates of death as well as hospitalization are observed in the short-term follow-up. Objective: To determine the prevalence, predictors, and prognostic value of RV function measured by the tricuspid annular plane systolic excursion (TAPSE) in patients with symptoms suggesting CHF.
Methods: Analysis of referrals for diagnosis and management of CHF to a specialist clinic serving a local community.
Results: Of 1547 patients studied, mean (SD) age was 71±11 years, 48% were women, mean LV ejection fraction (LVEF) was 47±16% and median (IQR) TAPSE was 18.5mm (14.0-22.7). LVEF was >45% in 47% and 67% were classified as heart failure. During a median (IQR) follow-up of 63 (41-75) months, overall mortality was 34%. In multivariable analysis, increasing age, NT-proBNP, NYHA class, atrial fibrillation, right atria volume, systolic pulmonary artery pressure (sPAP), lower TAPSE, lower diastolic blood pressure (DBP), lower haemoglobin, diagnosis of COPD, and digoxin and betablocker treatments were all associated with an adverse prognosis but not HF class. A receiver operator curve analysis investigating the relationship between TAPSE and prognosis showed an area under the curve of 0.69 (95%CI (0.64-0.74); p=0.0001), with a value of 15.9mm of TAPSE best able to predict outcome. TAPSE<15.9mm was most strongly associated when NTproBNP was not included in the model with raised in sPAP, DBP, heart rate and with decreased of BMI, eGFR and systolic BP, and presence of atrial fibrillation, ischaemic heart disease and with the severity of mitral regurgitation and S-HF.
Conclusion: In patients with symptoms of chronic heart failure, TAPSE, but not variables related to LV systolic function, was an independent predictor of outcome. This simple measure could be used to stratify patient risk in routine clinical practice. Acute myocarditis (AM) diagnosis is a challenge based on the association of clinical and para-clinical criteria. This pathology is thought to favour the evolution towards dilated cardiomyopathy and the occurrence of severe arrhythmias. Three months after the acute episode, re-evaluation including cardiac MRI could help to identify patients at risk for unfavourable evolution. The use of MRI has rarely been investigated in AM prognosis stratification.
Method and results:
we report a prospective series of 31 consecutive patients hospitalized for AM: 28 men and 3 women, 33 years old on average, without sign of heart failure. All patients presented with troponine I elevation. Echocardiography showed moderate global left ventricular dysfunction in 6 cases and segmental wall motion abnormalities in 18. MRI performed early after admission never showed myocardial first-pass perfusion defect after gadolinium injection but subepicardial delayed-enhancement (DE) areas in 29 cases mainly located in lateral segments. Three months after the acute episode, no patient was symptomatic. Echocardiography, Holter monitoring and biological check-up were normal. MRI showed the persistence of DE in 17 cases without wall motion abnormality in the affected segments. The presence of these latter abnormalities led to effect an annually clinical examination with an ECG. One patient was lost at further follow-up. Among the other 16 patients, none was symptomatic or displayed ECG abnormalities at 3-year mean follow-up.
Conclusions: at the time of admission, the absence of early perfusion defect at cardiac MRI after gadolinium injection and the subepicardial localization of the DE constitute reliable criteria in favour of AM diagnosis, allowing to rule out an acute coronary syndrome. During the follow-up the persistence of a DE does not allow any prognosis stratification. In our series after a mean 3-year follow-up, it is not associated with any clinical and paraclinical disorder.
